Morningside Group invests in private equity and venture capital opportunities.
Morningside Group is a private investment group founded in 1986 by the Chan family. The Chan family founded the Hang Lung Group in 1960. Today, the Hang Lung Group consists of Hang Lung Group Limited [0010.HK] and Hang Lung Properties Limited [0101.HK]. Both companies are listed on the Hong Kong Stock Exchange. Hang Lung Properties Limited is a constituent stock of the Hang Seng Index.Morningside Group invests in private equity and venture capital opportunities in North America, Europe, and the Asia Pacific. Since 1992, China has increasingly become a significant part of the group’s investment activities. Morningside Group has investments in the following sectors -- machinery manufacturing, high-tech, media, telecommunication, life science, education, and cleantech. The group is managed by experienced investment professionals who are entrepreneurial, have deep industry knowledge, and are effective in the local environment in which they operate.In addition to its investment activities, Morningside Group is deeply committed to being socially responsible. Providing access to educational opportunities and supporting scientific research are two major areas of focus for Morningside's philanthropic endeavors.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Sep 29, 2021
Semios
|
Private Equity(PE) | $100M | Agriculture | Yes |
Jun 18, 2020
Big Health
|
Series B | $39M | Health Care | Yes |
Oct 31, 2016
Cognoa
|
Series A | $3.82M | Biotechnology | Yes |
Jul 5, 2016
Innoventure
|
Series A | — | — | |
Apr 30, 2015
Mirna Therapeutics
|
Series D | $41.80M | Biotechnology | — |